McLean Hospital Corp: #16 Holder of Pervasive Neurotech Intellectual Property*

McLean Hospital CorpMcLean Hos­pi­tal is the third old­est psy­chi­atric hos­pi­tal in the Unit­ed States and is affil­i­at­ed with Har­vard Med­ical School. McLean’s research efforts in neu­ro­science and psy­chi­a­try span 66 lab­o­ra­to­ries and near­ly 400 research staff — it claims to have the largest research pro­gram of any pri­vate psy­chi­atric hos­pi­tal. Most of the research pro­grams at McLean are geared towards under­stand­ing and treat­ing men­tal ill­ness. Over the years, McClean’s research has yield­ed a num­ber of patents cov­er­ing tech­niques in non­in­va­sive neurotechnology.

  • Loca­tion: Bel­mont, MA
  • Stock Tick­er:
  • Num­ber of employ­ees: 1000–9999
  • Per­va­sive neu­rotech US patent grants: 15
  • Per­va­sive neu­rotech US pend­ing appli­ca­tions: 3

*McLean Hos­pi­tal Corp #16 in Sharp­Brains’ Per­va­sive Neu­rotech IP Strength Index, thanks to patents such as:

  • US6572528: Mag­net­ic field stim­u­la­tion techniques
  • US6475161: Meth­ods for diag­nos­ing Alzheimer’s dis­ease and oth­er forms of dementia
  • US7942828: Method for deter­min­ing fluc­tu­a­tion in atten­tion­al state and over­all atten­tion­al state
  • US6565518: Tech­nique for diag­nos­ing atten­tion deficit hyper­ac­tiv­i­ty disorder

To learn more about Sharp­Brains’ take on the orga­ni­za­tion’s #Per­va­siveNeu­rotech IP port­fo­lio, and over­all data and trends, click on Per­va­sive Neu­rotech­nol­o­gy: A Ground­break­ing Analy­sis of 10,000+ Patent Fil­ings Trans­form­ing Med­i­cine, Health, Enter­tain­ment, and Busi­ness.

About SharpBrains

SHARPBRAINS is an independent think-tank and consulting firm providing services at the frontier of applied neuroscience, health, leadership and innovation.
SHARPBRAINS es un think-tank y consultoría independiente proporcionando servicios para la neurociencia aplicada, salud, liderazgo e innovación.

Top Articles on Brain Health and Neuroplasticity

Top 10 Brain Teasers and Illusions

Newsletter

Subscribe to our e-newsletter

* indicates required

Got the book?